Latigo Biotherapeutics, Inc. (LTGO)

NASDAQ: LTGO · Real-Time Price · USD

12.60

-0.41 (-3.15%)

At close: Nov 6, 2026, 4:00 PM EST

12.57

-0.03 (-0.22%)

After-hours: Nov 6, 2026, 6:57 PM EST

Latigo Biotherapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-110.59	-110.39	-63.45
Net Income	-107.29	-109.17	-61.18
Earnings Per Share	-10.42	-129.23	-90.10
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	401.41	69.44	17.92
Total Debt	1.19	0.69	0.85
Net Cash (Debt)	400.22	68.75	17.07
Net Cash Growth	-	302.81%	-
Net Cash Per Share	38.85	81.38	25.13

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-	-97.56	-50.96
Capital Expenditures	-	-0.14	-0.07
Free Cash Flow	-	-97.69	-51.03
Free Cash Flow Growth	-	-	-